Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Sandler Neurology Drug: BIIB080 Company: Biogen Indication: Alzheimers disease Stage: Phase II Background: BIIB080 is an investigational antisense oligonucleotide (ASO) therapy designed to target microtubule-associated protein tau (MAPT) mRNA to reduce the production of tau protein
Melanotan I (afamelanotide, brand Scenesse) selectively targets MC1R for tanning with fewer side effects and is EU-approved for erythropoietic protoporphyria
Do you support customized service
In contrast to conventional pills or tablets, this inventive method avoids the digestion process, ensuring that stomach acids and enzymes do not neutralize the glutathione
US$ 29.87
US$ 20.61
US$ 28.60
US$ 29.34
US$ 20.71
US$ 26.52
US$ 25.28
US$ 26.15
US$ 22.28
US$ 23.76
